OICR BioLab: Magnetic Bioprinting of Cells

OICR BioLab: Magnetic Bioprinting of Cells

When and Where

Date: Wednesday, July 24, 2019 - Wednesday, July 24, 2019 (1 day)
Price: Free Location: 661 University Ave
West Tower, Suite 510 Toronto, ON, M5G 0A3 View map »

Registration Contact

Dr. Vanya Peltekova , Ph.D
Send Email »

Join us for free educational seminar on developing and utilization of 3D tumor model techniques, applications, and imaging modalities.

About this Event

BioLab at the Ontario Institute for Cancer Research (OICR) is hosting educational an seminar on: Magnetic 3D Bioprinting of Cells: an advance platform for developing organoid tumour models for high-throughput functional studies and drug screening on Wednesday, July 24, 2019, from 2 - 3:30 p.m. at OICR.

In this free educational event experts from Greiner Bio-One and BioTek will introduce the latest advances in 3D cell culture model techniques, tools, and imaging modalities, and discuss their applications for functional studies and drug screening.


With the advent of cost-effective, high-throughput 3D cell culture models, 3D CCMs spheroids, organoids, microtissues, and organs-on-a-chip), and rising demand for personalized therapies and drug screening, innovative in vitro predictive models using patient-derived cells are becoming very attractive.


BioLab has invited experts from leading biotech companies, Greiner Bio-One, and BioTek to present their innovative platforms for production, cultivation, and imaging of 3D cell culture models.

The keynote speakers include Dr. Glauco Souza, Director of Global Business Development and Innovation, Greiner Bio-One , and Dr. Anna Weichert, an imaging specialist and science consultant at BioTek.

The symposium will provide opportunities to:

• meet experts from leading 3D CCMs companies

• participate in a discussion on the utilization of 3D CCMs in cancer research and discovery.

Dr. Glauco Souza, Director of Global Business Development and Innovation, Greiner Bio-One, and Adjunct Assistant Professor, University of Texas Health Science Center, Houston, is a co-inventor of the magnetic 3D cell culture bioprinting. His work has been published in Nature Nanotechnology, PNAS, Nature Protocols, and Nature Reviews Cancer.

Dr. Anna Weichert is an imaging specialist and science consultant with BioTek Instruments. She has a Ph.D. in Biology from Johannes Gutenberg University Mainz, Germany, and post doctorate from Tanz Centre for Research in Neurodegenerative Diseases, Toronto. She is an expert on microplate detection, microscopy (confocal, live cell, and 2-photon), and image analysis.


2 - 3 p.m. - Magnetic 3D cell (m3D) bioprinting: in vitro spheroid platform for rapid, high-throughput drug screening

Dr. Glauco Souza, Director of Global Business Development and Innovation, Greiner Bio-One

An overview of the Greiner Bio-One on their innovative magnetic nanoparticle platform that combines specialized high-density microtiter plates and gold nanoparticles for fast generation of 3D spheroid or organoid structures and its use for drug screening.

3 - 3:30 p.m. - 3D cell culture and imaging solutions by BioTek

Dr. Anna Weichert, Imaging Specialist, BioTek Instruments

Imaging and analysis of 3D cancer cell models for drug screening are challenging due to cell aggregations, sample thickness, and limitations for time-sensitive kinetic assays. Scientists from BioTek will discuss Lionheart FX, Cytation, BioSpa 8, and software for visualization and accurate image analysis of 3D cell cultures.

Pathologists and Researchers who are interested in being part of the OMPRN: